Oracle VM VirtualBox 7.2.16 Core privileges management
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 8.3 | $5k-$25k | 0.45- |
Summary
A vulnerability was found in Oracle VM VirtualBox 7.2.16. It has been rated as very critical. Affected is an unknown function of the component Core. This manipulation causes privileges management. The identification of this vulnerability is CVE-2026-87270. The attack can only be executed locally. There is no exploit available.
Details
A vulnerability was found in Oracle VM VirtualBox 7.2.16. It has been declared as very critical. Affected by this vulnerability is an unknown function of the component Core. The manipulation with an unknown input leads to a privileges management vulnerability. The CWE definition for the vulnerability is CWE-269. The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor. As an impact it is known to affect confidentiality, integrity, and availability. The summary by CVE is:
Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). The supported version that is affected is 7.2.16. Easily exploitable vulnerability allows low privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. Successful attacks of this vulnerability can result in takeover of Oracle VM VirtualBox. Note: This vulnerability applies to Windows host only. CVSS 3.1 Base Score 7.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).
The advisory is shared at oracle.com. This vulnerability is known as CVE-2026-87270 since 09/08/2026. The exploitation appears to be easy. An attack has to be approached locally. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $5k-$25k at the moment (estimation calculated on 09/16/2026). MITRE ATT&CK project uses the attack technique T1068 for this issue.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 8.3VulDB Meta Temp Score: 8.3
VulDB Base Score: 8.8
VulDB Temp Score: 8.8
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 7.8
CNA Vector (oracle): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Privileges managementCWE: CWE-269 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: Partially
Local: Yes
Remote: No
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
09/08/2026 CVE reserved09/16/2026 Advisory disclosed
09/16/2026 VulDB entry created
09/16/2026 VulDB entry last update
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
CVE: CVE-2026-87270 (🔒)
GCVE (CVE): GCVE-0-2026-87270
GCVE (VulDB): GCVE-100-405349
Entry
Created: 09/16/2026 02:33Changes: 09/16/2026 02:33 (62)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.